0001209191-22-033719.txt : 20220602 0001209191-22-033719.hdr.sgml : 20220602 20220602191401 ACCESSION NUMBER: 0001209191-22-033719 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220531 FILED AS OF DATE: 20220602 DATE AS OF CHANGE: 20220602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Piekos Brian CENTRAL INDEX KEY: 0001815308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39438 FILM NUMBER: 22992546 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemini Therapeutics, Inc. /DE CENTRAL INDEX KEY: 0001816736 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851613057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 401-4400 MAIL ADDRESS: STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: FS Development Corp. DATE OF NAME CHANGE: 20200702 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-31 0 0001816736 Gemini Therapeutics, Inc. /DE GMTX 0001815308 Piekos Brian 297 BOSTON POST ROAD #248 WAYLAND MA 01778 0 1 0 0 CFO Common Stock 2022-05-31 4 A 0 9960 1.09 A 17615 D These shares were acquired under the Gemini Therapeutics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"). In accordance with the terms of the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 31, 2022. /s/ Brian Piekos 2022-06-02